National Health Investors, Inc. (NYSE: NHI), a real estate investment trust focused on senior housing and medical investments, currently holds a consensus rating of "Hold" with an average price target of $85.50. The company reported earnings of $1.13 per share, exceeding estimates, and announced a quarterly dividend of $0.90, yielding 4.79%. Institutional investors own 62.51% of the stock, with Barclays PLC increasing its stake by 7.6% in the last quarter.